Stan Stoyanov M.D.

Stan Stoyanov MD, MBA is an experienced clinical development leader with a strong background in the pharmaceutical and biotherapeutic industries. Currently serving as VP of Clinical Development at SAb Biotherapeutics, Stan has previously held significant roles, including Anti-TL1A IBD Clinical Development Physician/CDP Lead and Interim Immunology & IO TA Head at Teva Pharmaceuticals. Additional experience includes serving as VP of Clinical Development at Krystal Biotech, Inc., Executive Director of Clinical Research and Cholestasis Lead at Intercept Pharmaceuticals, and Senior Director and Therapeutic Area Head in Respiratory at Teva Pharmaceuticals. Stan's diverse expertise spans clinical research, innovative medicine, and strategic leadership within global clinical development.